ALXO Jun 2024 16.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:23AM EDT. Market open.
| Previous close | 3.0200 |
| Open | 1.6000 |
| Bid | 0.7000 |
| Ask | 5.0000 |
| Strike | 16.00 |
| Expiry date | 2024-06-21 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksDeciphera's (DCPH) Shares Surge 74.3% in a Month: Here's Why
Deciphera (DCPH) soars 74.3% in the past month on a $2.4 billion buy-out offer from ONO Pharmaceuticals. The transaction is expected to close in the third quarter of 2024.
ZacksDr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Dr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop and commercialize the latter's biosimilar candidate, AVT03, to Prolia and Xgeva.
GuruFocus.comInsider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
Sophia Randolph, Chief Medical Officer of ALX Oncology Holdings Inc (NASDAQ:ALXO), sold 12,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.